OptimizeRx Corp [NASDAQ: OPRX] price surged by 51.69 percent to reach at $2.14.
The one-year OPRX stock forecast points to a potential upside of 35.32. The average equity rating for OPRX stock is currently 1.50, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on OptimizeRx Corp [OPRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OPRX shares is $9.71 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OPRX stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for OptimizeRx Corp shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on January 08, 2025. While these analysts kept the previous recommendation, Stephens raised their target price to Equal-Weight. The new note on the price target was released on December 20, 2024, representing the official price target for OptimizeRx Corp stock. Previously, the target price had yet another raise to $18.50, while B. Riley Securities analysts kept a Buy rating on OPRX stock.
The Average True Range (ATR) for OptimizeRx Corp is set at 0.57, with the Price to Sales ratio for OPRX stock in the period of the last 12 months amounting to 1.31. The Price to Book ratio for the last quarter was 1.01, with the Price to Cash per share for the same quarter was set at 0.88.
OPRX Stock Performance Analysis:
OptimizeRx Corp [OPRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.35. With this latest performance, OPRX shares gained by 10.95% in over the last four-week period, additionally sinking by -12.78% over the last 6 months – not to mention a drop of -61.16% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OPRX stock in for the last two-week period is set at 60.90, with the RSI for the last a single of trading hit 65.71, and the three-weeks RSI is set at 58.10 for OptimizeRx Corp [OPRX]. The present Moving Average for the last 50 days of trading for this stock 5.41, while it was recorded at 4.80 for the last single week of trading, and 7.32 for the last 200 days.
Insight into OptimizeRx Corp Fundamentals:
OptimizeRx Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.23 and a Current Ratio set at 3.23.
OptimizeRx Corp [OPRX] Institutonal Ownership Details
There are presently around $64.95%, or 75.48%% of OPRX stock, in the hands of institutional investors. The top three institutional holders of OPRX stocks are: FIRST LIGHT ASSET MANAGEMENT, LLC with ownership of 1.83 million shares, which is approximately 10.0548%. DIVISADERO STREET CAPITAL MANAGEMENT, LP, holding 1.32 million shares of the stock with an approximate value of $$13.16 million in OPRX stocks shares; and DIVISADERO STREET CAPITAL MANAGEMENT, LP, currently with $$11.75 million in OPRX stock with ownership which is approximately 6.4689%.
